Sarah Singleton, APRN
Nurse Practitioner · Bainbridge Island, WANPI 1932365228
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,446 of the $1,646 with a category attached, or 87.8%. 16 manufacturers reported payments, led by Amgen at 29.0% of the total. Reporting peaked in 2023 at $555 and has fallen 97.4% since, to $15 in 2025. Among nurse practitioner clinicians in WA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 74 payments — averaging $22.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$478
- Johnson & Johnson$387
- AbbVie$345
- Sanofi$85
- Lilly USA, LLC$67
- Biofrontera Inc.$55
- plus $230 from 10 others
What the payments were for
- Food & beverage$1,44688%
- Education$20012%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 21 | $478 |
| Johnson & Johnson | 13 | $387 |
| AbbVie | 17 | $345 |
| Sanofi | 4 | $85 |
| Lilly USA, LLC | 3 | $67 |
| Biofrontera Inc. | 4 | $55 |
| Incyte Corporation | 2 | $47 |
| LEO Pharma Inc. | 2 | $31 |
| VYNE Pharmaceuticals Inc. | 1 | $27 |
| Almirall LLC | 1 | $24 |
| Novartis | 1 | $24 |
| Regeneron Healthcare Solutions, Inc. | 1 | $18 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $16 |
| Dermavant Sciences, Inc. | 1 | $16 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $15 |
| Novo Nordisk | 1 | $13 |
How this compares
$1,646 in reported general payments places this provider in the 90th percentile of 2,466 nurse practitioner providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 16 | $891 |
| Econazole Nitrate | 19 | $644 |
| Fluorouracil | 12 | $596 |
| Ketoconazole | 42 | $522 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Bainbridge Island
- Trisia DumpitBainbridge Island$10K
- Olga VoloshinaSeattle$279K
- Sandra ChristensenSeattle$244K
- Felicia ForrestLynnwood$206K
- Amaris MurphyBellevue$146K
- Sonia GlennieSeattle$78K
- Megan WildesTacoma$72K
- Kate KennedyBellevue$63K
- Vicki HainesPasco$57K
- Jessica ArmitageSumner$46K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.